CH391L/S12/Artemisinic Acid Engineering

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
Line 24: Line 24:
==Previous iGEM Examples==
==Previous iGEM Examples==
 +
 +
There has been no incidence of previous iGEM teams investigating Artemisinin or any of its precursors. Many iGEM teams have referenced Ro et al., but only as an example of pathway engineering, or in order to discuss ethics and synthetic biology's potential to positively benefit society.
http://en.wikipedia.org/wiki/Artemisinin
http://en.wikipedia.org/wiki/Artemisinin
==References==
==References==
<biblio>
<biblio>
-
#Dae-Kyun2006 pmid=16612385
+
#Ro2006 pmid=16612385
//
//

Revision as of 18:24, 2 April 2012


  • NOTE* Page is still under construction. As long as this note appears, assume information presented on this page is incomplete and unreliable.

Contents

Introduction

Types of Selectable Markers

Antibiotic

Herbicidal

Auxotrophic

Other

Types of Screening

Blue/White Screening

Green Fluorescent Protein Screening

Artificial Selection

Previous iGEM Examples

There has been no incidence of previous iGEM teams investigating Artemisinin or any of its precursors. Many iGEM teams have referenced Ro et al., but only as an example of pathway engineering, or in order to discuss ethics and synthetic biology's potential to positively benefit society.

http://en.wikipedia.org/wiki/Artemisinin

References

  1. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, and Keasling JD. . pmid:16612385. PubMed HubMed [Ro2006]
  2. Chang MC, Eachus RA, Trieu W, Ro DK, and Keasling JD. . pmid:17438551. PubMed HubMed [Chang2007]
All Medline abstracts: PubMed HubMed
Personal tools